Paula I. Burgos

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells.

Therapeutic role of interferon-γ in experimental autoimmune encephalomyelitis is mediated through a tolerogenic subset of splenic CD11b+ myeloid cells.

Journal: Journal of neuroinflammation

Published: March 26, 2024

Performance of the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease in a Latin American Cohort.

Performance of the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease in a Latin American Cohort.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: January 11, 2024

Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.

Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.

Journal: Clinical rheumatology

Published: September 11, 2023

Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia.

Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia.

Journal: Frontiers in immunology

Published: March 22, 2023

Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients.

Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients.

Journal: Lupus

Published: August 29, 2022

Clinical and Serological Features in Latin American IgG4-Related Disease Patients Differ According to Sex, Ethnicity, and Clinical Phenotype.

Clinical and Serological Features in Latin American IgG4-Related Disease Patients Differ According to Sex, Ethnicity, and Clinical Phenotype.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: May 25, 2022

Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine.

Humoral immune-response to a SARS-CoV-2-BNT162b2 booster in inflammatory arthritis patients who received an inactivated virus vaccine.

Journal: Annals of the rheumatic diseases

Published: January 20, 2022

Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile.

Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 30, 2021

Rheumatology Training in Latin America: A Collaborative Study by the Pan American League of Associations for Rheumatology.

Rheumatology Training in Latin America: A Collaborative Study by the Pan American League of Associations for Rheumatology.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: August 04, 2021

Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America.

Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America.

Journal: Rheumatology international

Published: July 01, 2021

Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America.

Impact of COVID-19 Pandemic on Rheumatology Practice in Latin America.

Journal: The Journal of rheumatology

Published: May 28, 2021

Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.

Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.

Journal: Journal of autoimmunity

Published: April 24, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026